RVT-1502 clinical trials
Also written LGD-6972.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses RVT-1502 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses RVT-1502 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of LGD-6972 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Ligand PharmaceuticalsNCT02851849Written as LGD-6972-5 mgHow we know
- A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution FormulationCompletedPhase 1Ligand PharmaceuticalsNCT02672839Written as LGD-6972 SolutionHow we know
- Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes MellitusCompletedPhase 1Ligand PharmaceuticalsNCT02250222Written as LGD-6972How we know
- Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes MellitusCompletedPhase 1Ligand PharmaceuticalsNCT01919684Written as LGD-6972How we know
Codes
What other systems call RVT-1502 · ClinicalTrials.gg INT000819
- MeSH (NLM) C000624432RVT-1502One source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000624432 | RVT-1502 | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.